NO962943L - Peptider og fremgangsmåte mot psoriasis - Google Patents

Peptider og fremgangsmåte mot psoriasis

Info

Publication number
NO962943L
NO962943L NO962943A NO962943A NO962943L NO 962943 L NO962943 L NO 962943L NO 962943 A NO962943 A NO 962943A NO 962943 A NO962943 A NO 962943A NO 962943 L NO962943 L NO 962943L
Authority
NO
Norway
Prior art keywords
psoriasis
present
cell
peptide
fragment
Prior art date
Application number
NO962943A
Other languages
English (en)
Norwegian (no)
Other versions
NO962943D0 (no
Inventor
Jennie C C Chang
Steven W Brostoff
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of NO962943D0 publication Critical patent/NO962943D0/no
Publication of NO962943L publication Critical patent/NO962943L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
NO962943A 1994-01-14 1996-07-12 Peptider og fremgangsmåte mot psoriasis NO962943L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/182,967 US6413516B1 (en) 1989-03-21 1994-01-14 Peptides and methods against psoriasis
PCT/US1995/000658 WO1995019375A1 (fr) 1994-01-14 1995-01-13 Peptides et procedes contre le psoriasis

Publications (2)

Publication Number Publication Date
NO962943D0 NO962943D0 (no) 1996-07-12
NO962943L true NO962943L (no) 1996-09-13

Family

ID=22670842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962943A NO962943L (no) 1994-01-14 1996-07-12 Peptider og fremgangsmåte mot psoriasis

Country Status (14)

Country Link
US (1) US6413516B1 (fr)
EP (1) EP0738281B1 (fr)
JP (2) JPH09508112A (fr)
CN (1) CN1138865A (fr)
AT (1) ATE227738T1 (fr)
BR (1) BR9506511A (fr)
CA (1) CA2179280A1 (fr)
DE (1) DE69528817T2 (fr)
ES (1) ES2184791T3 (fr)
FI (1) FI962836A (fr)
MX (1) MX9602473A (fr)
NO (1) NO962943L (fr)
NZ (1) NZ279987A (fr)
WO (1) WO1995019375A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
JP2009266963A (ja) * 2008-04-23 2009-11-12 Sumitomo Electric Ind Ltd 窒化物系発光素子、及び半導体発光素子を製造する方法
EP4211170A1 (fr) * 2020-09-11 2023-07-19 Janssen Biotech, Inc. Méthodes et compositions pour moduler l'immunité médiée par la chaîne bêta
US20240123022A1 (en) 2021-12-16 2024-04-18 Ramakrishna Reddy ISANAKA A stable anti-angiogenic and anti-inflammatory pharmaceutical formulation and pharmaceutical combination for treatment and prevention of psoriasis
CN116466095B (zh) * 2023-06-15 2023-09-01 朗肽生物制药股份有限公司 一种多肽及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70553A1 (en) * 1984-03-01 2000-02-22 Univ Leland Stanford Junior T-cell receptor-specific for antigen polypeptides and related polynucleotides
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
NZ234586A (en) * 1989-07-19 1993-02-25 Arthur Allen Vandenbark Peptide of a t-cell receptor capable of inducing protection from immune-related disease
CA2072356A1 (fr) * 1989-12-29 1991-06-30 James L. Urban Diagnostic et traitement des maladies
JPH06511241A (ja) 1991-09-23 1994-12-15 ジェネンテク，インコーポレイテッド 自己免疫疾患の診断および治療
JPH07506563A (ja) * 1991-12-24 1995-07-20 ザ　イミューン　レスポンス　コーポレイション 特異的ｔ細胞群による病原応答に起因する疾患に対してのワクチン接種および方法

Also Published As

Publication number Publication date
US6413516B1 (en) 2002-07-02
AU1728295A (en) 1995-08-01
CA2179280A1 (fr) 1995-07-20
DE69528817T2 (de) 2003-09-11
MX9602473A (es) 1997-05-31
BR9506511A (pt) 1997-09-09
JP2001288108A (ja) 2001-10-16
FI962836A0 (fi) 1996-07-12
EP0738281B1 (fr) 2002-11-13
NZ279987A (en) 1999-09-29
ATE227738T1 (de) 2002-11-15
FI962836A (fi) 1996-07-12
ES2184791T3 (es) 2003-04-16
JPH09508112A (ja) 1997-08-19
NO962943D0 (no) 1996-07-12
WO1995019375A1 (fr) 1995-07-20
CN1138865A (zh) 1996-12-25
EP0738281A1 (fr) 1996-10-23
AU697910B2 (en) 1998-10-22
DE69528817D1 (de) 2002-12-19

Similar Documents

Publication Publication Date Title
Lobb et al. Immunoglobulin light chain classes in a teleost fish.
NO964650D0 (no) LAG-3 protein-opplöselige polypeptidfraksjoner, fremgangsmåte for fremstilling, teraupeutisk preparat og anti-idiotype antistoff
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
EP0815125A4 (fr) RECEPTEUR gC1q, ZONE DE LIAISON DE gp120 DE VIH-1 A CE DERNIER, ET PEPTIDES ET ANTICORPS DE CIBLAGE ASSOCIES
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
NO913211L (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
AU1986588A (en) Growth hormone receptor
ES8801373A1 (es) Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo
ATE106943T1 (de) Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie.
ES8802160A1 (es) Un procedimiento para aislar un gen de relaxina cromosomica de un ser humano o de otro primate o una especie afin
ATE282634T1 (de) Chaperonin 10
NO962943L (no) Peptider og fremgangsmåte mot psoriasis
DK0687180T3 (da) Fremgangsmåde til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-anti
NO963366L (no) Peptider og fremgangsmåte for behandling av diabetes
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
MY127669A (en) Polypeptide hormone phosphatonin
ES8503373A1 (es) Un procedimiento de preparacion de un vector de transferencia de adn.
EP0662150A4 (fr) Maspin, nouveau serpin a activite antitumorale.
EP1986011A3 (fr) Épitopes peptidiques identifiés par des lymphocytes T auxiliaires stimulant la maladie
KR930019827A (ko) 신규 폴리펩티드 및 이를 암호하는 dna
Czarnocka et al. Further Evidence that Thyroid Peroxidase and the “Microsomal Antigen” are the Same Entity
NZ334649A (en) Iron regulated promoter derived from an aerobactin gene promoter
NO996210L (no) Peptider og forbindelser som bindes til IL-5-reseptorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application